Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2012
07/04/2012CN101439082B Chinese medicine granule containing sophora root extract and preparation method thereof
07/04/2012CN101437853B Biocompatible three dimensional matrix for the immobilization of biological substances
07/04/2012CN101428141B Recombinant human vascular endothelial inhibitor sustained-release injection oil formulation and preparation thereof
07/04/2012CN101389353B Enteric gelatinous nutrient and method of preparing the same
07/04/2012CN101375845B Podophyllotoxin external-use formulation prescription for treating pointed condyloma and herpes genitalis, dosage form series and preparation method
07/04/2012CN101375834B Solid dispersion of Ailamode and preparation method thereof and medicament application
07/04/2012CN101365671B Isohumulone compound clathrate and composition containing the same
07/04/2012CN101357939B Protein conjugate and pharmaceutical compositions thereof
07/04/2012CN101321870B Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
07/04/2012CN101282717B Bitterness-reducing agent
07/04/2012CN101259120B Methods of inducing terminal differentiation
07/04/2012CN101092455B Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
07/04/2012CN101088522B Chinese medicine composition containing red sage, notoginseng and musk or muskone and its prepn
07/04/2012CN101085064B Composition containing radix paeoniae rubrathe for treating cardiovascular diseases and its preparation
07/04/2012CN101057968B Oxyntomodulin for preventing or treating excess weight
07/04/2012CN101035823B Amphiphilic star block copolymers
07/04/2012CN101024084B Use of debranched starch in extrusive globurized medicine pellet
07/04/2012CN101023950B Allopurinol sodium sterilzed powder for injection and preparing method
07/03/2012US8212082 Process for the isolation of dodecatrienal and its use as aroma substance
07/03/2012US8212004 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders
07/03/2012US8211948 Lyophilized nanoemulsion
07/03/2012US8211946 Pharmaceutical formulation
07/03/2012US8211942 Compositions and methods for dry eye syndrome
07/03/2012US8211887 Topical preparation and method for transdermal delivery and localization of therapeutic agents
07/03/2012US8211487 Inhibition of ice crystal growth
07/03/2012US8211475 Process for preparing nanoparticles of chitosan in water phase
07/03/2012US8211473 Stable formulations for lyophilizing therapeutic particles
07/03/2012US8211467 Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
07/03/2012US8211435 Calf biologic anti-scour supplement (CBAS)
07/03/2012CA2665567C Stable formulations
07/03/2012CA2526202C Compositions for treating infection in cattle and swine
07/03/2012CA2517135C 1-n-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
07/03/2012CA2503647C Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
07/03/2012CA2500713C Photokinetic delivery of biologically active substances using pulsed incoherent light
07/03/2012CA2493464C Microcapsules with modified release of active principles with low solubility for oral delivery
07/03/2012CA2492789C Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
07/03/2012CA2484140C Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units
07/03/2012CA2471041C Compositions and methods for enhancing corticosteriod delivery
07/03/2012CA2468958C Pulmonary delivery of aminoglycosides
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2413164C Process for producing isomaltose and use thereof
07/02/2012CA2806314A1 Method for purifying active polypeptides or immunoconjugates
06/2012
06/28/2012WO2012088529A1 Polymer-sunitinib conjugates
06/28/2012WO2012088522A1 Polymer-des-ethyl sunitinib conjugates
06/28/2012WO2012088506A1 Polymer-semaxanib moiety conjugates
06/28/2012WO2012088445A1 Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
06/28/2012WO2012088422A1 Multi-arm polymeric prodrug conjugates of taxane-based compounds
06/28/2012WO2012088306A2 Two-piece injectable drug delivery device with heat-cured seal
06/28/2012WO2012088282A1 Multi-arm polymeric prodrug conjugates of pemetrexed-based compounds
06/28/2012WO2012087962A2 Anti-mesothelin antibodies and immunoconjugates
06/28/2012WO2012087838A1 Materials and methods for conjugating a water soluble fatty acid derivative to a protein
06/28/2012WO2012087823A2 Ph-induced silk fibroin gels and uses thereof
06/28/2012WO2012087725A1 Use of aniline iν the radiostabilization of oxime ligation
06/28/2012WO2012087620A2 Carbon containing low-k dielectric constant recovery using uv treatment
06/28/2012WO2012087517A2 Cosmetic films
06/28/2012WO2012087326A1 Fluid compositions comprising a structuring agent
06/28/2012WO2012087255A2 Pharmaceutical formulations
06/28/2012WO2012087062A2 Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same
06/28/2012WO2012087051A2 Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same
06/28/2012WO2012086857A1 Combination body for photodynamic diagnosis or therapy and a production method therefor
06/28/2012WO2012086760A1 Disinfectant
06/28/2012WO2012086712A1 Elution-controlled oral liquid preparation
06/28/2012WO2012086593A1 Viscous nutritional composition
06/28/2012WO2012086157A1 Method of intensifying the physiological action of caffeine
06/28/2012WO2012085847A2 Triggered polymer viscous pill and methods of using the same
06/28/2012WO2012085793A1 Use of pegylated recombinant human arginase for treatment of leukemia
06/28/2012WO2012085789A1 Agents for clearing biomolecules from circulation
06/28/2012WO2012085304A1 Phosphomycin pharmaceutical composition
06/28/2012WO2012085303A1 Polymer compounds having immobilizing properties
06/28/2012WO2012085236A1 Solid retard formulations based on solid dispersions
06/28/2012WO2012085171A2 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012WO2012085072A1 Gas-filled microvesicles for use as vaccine
06/28/2012WO2012085068A1 Kit-in-parts for cleaning and treating ears of companion animals
06/28/2012WO2012085018A1 Pharmaceutical composition containing active vegetable substances
06/28/2012WO2012084951A1 Enhanced immune response in bovine species
06/28/2012WO2012084754A2 Pharmaceutical glp-1 compositions having an improved release profile
06/28/2012WO2012083947A1 Chewing gum composition comprising cross-linked polyacrylic acid
06/28/2012WO2012083592A1 Artificial oil body carrier used for targeted breast cancer therapy and preparation method and application of the same
06/28/2012WO2012059873A3 Anti-diabetic compounds
06/28/2012WO2012057628A3 Cross-linked polymers and implants derived from electrophilically activated polyoxazoline
06/28/2012WO2012057525A3 Liquid formulations of long acting interferon alpha conjugate
06/28/2012WO2012054717A3 Detecting and treating solid tumors through selective disruption of tumor vasculature
06/28/2012WO2012053785A3 Sustained-release pellets containing tacrolimus as an active ingredient
06/28/2012WO2012051204A3 Antimicrobial formulations that aid in wound healing
06/28/2012WO2012049324A3 New emd formulation comprising pga
06/28/2012WO2012032068A3 Compounds and methods
06/28/2012WO2012013331A3 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
06/28/2012WO2012007584A3 Composition for the treatment of superficial lesions
06/28/2012WO2011156481A3 Formulations including amiodarone and salts thereof and methods of their manufacture and use
06/28/2012WO2011154725A3 Compositions comprising buprenorphine
06/28/2012WO2011154505A3 Complex product comprising a cellular carrier and a cytoxic chemotherapeutic drug
06/28/2012WO2011150144A3 Aqueous formulations for coating microneedle arrays
06/28/2012WO2011130716A3 A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers
06/28/2012WO2011128630A3 Anti-abuse gelled pharmaceutical compositions
06/28/2012US20120165415 Emulsion system derives from engkabang fat esters
06/28/2012US20120165413 Disintegrating particle composition and orally rapidly disintegrating tablet
06/28/2012US20120165361 Drug coating providing high drug loading and methods for providing the same
06/28/2012US20120165302 Antifungal formulations
06/28/2012US20120165291 Acidic composition for external use and agent for accelerating infiltration of cosmetic preparation, hair-growing agent, and preparation for external use each containing the composition into skin or the like
1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 1712